Publicacions
-
Esther Pousa Tomas, Ochoa S, Cobo JV, María de Lourdes Nieto García, Usall J, González B, Garcia-Ribera C, Pérez-Solà V, Ruiz A and Insight Barcelona Research Group.
A deeper view of insight in schizophrenia: Insight dimensions, unawareness and misattribution of particular symptoms and its relation with psychopathological factors
SCHIZOPHRENIA RESEARCH . 189: 61-68. Nº de cites: 26
-
Puig O, Baeza I, de la Serna E, Cabrera B, Mezquida G, Bioque M, Lobo A, González-Pinto A, Parellada M, Corripio I, Vieta E, Bobes J, Usall J, Contreras F, Cuesta MJ, Bernardo M, Castro-Fornieles J and Group TP.
Persistent Negative Symptoms in First-Episode Psychosis: Early Cognitive and Social Functioning Correlates and Differences Between Early and Adult Onset.
JOURNAL OF CLINICAL PSYCHIATRY . 78(9): 1414-1422. Nº de cites: 25
-
Huerta-Ramos ME, Marcó-García S, Escobar-Villegas MS, Rubio E, Ochoa S, Grasa Bello EM, Alonso Solís A, Rabella M, Berdun J, Hospedales M, M-Resist G, Corripio I and Usall J.
m-RESIST, a complete m-Health solution for patients with treatmentresistant schizophrenia: a qualitative study of user needs and acceptability in the Barcelona metropolitan area.
ACTAS ESPANOLAS DE PSIQUIATRIA . 45(6): 277-289. Nº de cites: 4
-
MacDowell KS, Pinacho R, Leza JC, Costa Escolà J, Ramos B and García-Bueno B.
Differential regulation of the TLR4 signalling pathway in post-mortem prefrontal cortex and cerebellum in chronic schizophrenia: Relationship with SP transcription factors.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY . 79(Pt B): 481-492. Nº de cites: 26
-
Garriga M, Solé E, González-Pinto A, Selva-Vera G, Arranz B, Amann BL, Saiz-Ruiz J, Pérez-Blanco J and Vieta E.
Efficacy of quetiapine XR vs. placebo as concomitant treatment to mood stabilizers in the control of subthreshold symptoms of bipolar disorder: Results from a pilot, randomized controlled trial.
EUROPEAN NEUROPSYCHOPHARMACOLOGY . 27(10): 959-969. Nº de cites: 12
-
Stephan-Otto C, Siddi S, Carl Senior, Cuevas-Esteban J, Cambra-Martí MR, Ochoa S and Brebion G.
Remembering verbally-presented items as pictures: Brain activity underlying visual mental images in schizophrenia patients with visual hallucinations.
Cortex . 94: 113-122. Nº de cites: 15
-
Riera M, Castells X, Tobias A, Cunill R, Blanco L and Capellà D.
Discontinuation of pharmacological treatment of children and adolescents with attention deficit hyperactivity disorder: meta-analysis of 63 studies enrolling 11,788 patients.
Psychopharmacology . 234(17): 2657-2671. Nº de cites: 18
-
Cuevas-Esteban J, Iglesias M, Rubio-Valera M, Serra-Mestres J, Serrano-Blanco A and Baladon L.
Prevalence and characteristics of catatonia on admission to an acute geriatric psychiatry ward.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY . 78: 27-33. Nº de cites: 20
-
Folch-Mas A, Cortés-Ruiz MJ, Salvador-Carulla L, Natalia Kazah Soneyra, Irazábal M, Muñoz-Lorente S, Tamarit-Cuadrado J and Martínez-Leal R.
Nuevas consideraciones sobre la salud de las personas con trastornos del desarrollo intelectual.
SALUD PUBLICA DE MEXICO . 59(4): 454-461. Nº de cites: 3
-
Mas S, Gassó P, Torra M, Bioque M, Lobo A, González-Pinto A, Olmeda MS, Corripio I, Vieta E, Castro-Fornieles J, Rodriguez-Jimenez R, Bobes J, Usall J, Llerena A, Saiz-Ruiz J, Bernardo M, Lafuente A and PEPs Group.
Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients.
EUROPEAN NEUROPSYCHOPHARMACOLOGY . 27(7): 647-656. Nº de cites: 8